Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature

Recruiting

Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral VasculatureDrug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature

Sponsor:

Boston Scientific Corporation

Code:

NCT04674969

Conditions

Peripheral Vascular Diseases

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Any eligible commercially available Boston Scientific Corporation (BSC) drug-eluting device.

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by Boston Scientific Corporation on 2025-03-25.